Issue:
A major pharmaceutical client sought to better understand patient demographics, clinical characteristics, treatment trajectories, healthcare resource use, costs and survival outcomes among patients with esophageal and gastric cancers in China, South Korea, Taiwan, Japan, and the U.S.
Solution:
- We conducted a five-country study using a standard study protocol with specific country modifications simultaneously. This study was conducted using members of our collaborator network to access and analyze the data, as well as by DMS using our commercial data provider network.
- This study revealed deep insight in the real-world management of esophageal and gastric cancers. Specific treatment trajectories were explored, along with patient characteristics, clinical parameters, healthcare resource use, costs and survival outcomes at each line of treatment. Findings from these analyses were compared to pivotal RCTs conducted by the client company.
- The results from these analyses were utilized by the target countries for discussions with reimbursement authorities and were also published or presented as abstracts, posters and manuscripts in the target countries as well as in global peer-reviewed conferences and clinical journals.
